Beta Cell Dysfunction in Youth- and Adult-Onset Type 2 Diabetes: An Extensive Narrative Review with a Special Focus on the Role of Nutrients
Overview
Authors
Affiliations
Traditionally a disease of adults, type 2 diabetes (T2D) has been increasingly diagnosed in youth, particularly among adolescents and young adults of minority ethnic groups. Especially, during the recent COVID-19 pandemic, obesity and prediabetes have surged not only in minority ethnic groups but also in the general population, further raising T2D risk. Regarding its pathogenesis, a gradually increasing insulin resistance due to central adiposity combined with a progressively defective β-cell function are the main culprits. Especially in youth-onset T2D, a rapid β-cell activity decline has been observed, leading to higher treatment failure rates, and early complications. In addition, it is well established that both the quantity and quality of food ingested by individuals play a key role in T2D pathogenesis. A chronic imbalance between caloric intake and expenditure together with impaired micronutrient intake can lead to obesity and insulin resistance on one hand, and β-cell failure and defective insulin production on the other. This review summarizes our evolving understanding of the pathophysiological mechanisms involved in defective insulin secretion by the pancreatic islets in youth- and adult-onset T2D and, further, of the role various micronutrients play in these pathomechanisms. This knowledge is essential if we are to curtail the serious long-term complications of T2D both in pediatric and adult populations.
Impact of Olive Oil Components on the Expression of Genes Related to Type 2 Diabetes Mellitus.
Munteanu C, Kotova P, Schwartz B Nutrients. 2025; 17(3).
PMID: 39940428 PMC: 11820997. DOI: 10.3390/nu17030570.
Fang H, Li X, Lv J, Huo X, Guo M, Liu X J Diabetes Res. 2024; 2024:9683512.
PMID: 39474247 PMC: 11521580. DOI: 10.1155/2024/9683512.
Youth-onset Type 2 Diabetes: An Overview of Pathophysiology, Prognosis, Prevention and Management.
Titmuss A, Korula S, Wicklow B, Nadeau K Curr Diab Rep. 2024; 24(8):183-195.
PMID: 38958831 PMC: 11269415. DOI: 10.1007/s11892-024-01546-2.
Schwartz S, Herman M Front Endocrinol (Lausanne). 2024; 15:1394805.
PMID: 38933821 PMC: 11199379. DOI: 10.3389/fendo.2024.1394805.
Early onset type 2 diabetes mellitus: an update.
Strati M, Moustaki M, Psaltopoulou T, Vryonidou A, Paschou S Endocrine. 2024; 85(3):965-978.
PMID: 38472622 PMC: 11316703. DOI: 10.1007/s12020-024-03772-w.